Life science and drug discovery researchers interested in bioluminescent tools will have the opportunity to hear from global thought leaders on the possibilities and applications of luciferase technologies during the upcoming Discover Glo 2021 virtual seminar series. Hosted by Promega and held September 13-16, the series will advance understanding in important therapeutic areas such as Targeted Protein Degradation and Kinase Biology.
Over the last three decades, assays and technologies utilizing the natural phenomenon of bioluminescence have gone from novel research tools to foundational elements of the modern research toolbox. Innovation utilizing bioluminescent approaches continues, further expanding both the available methods and the scientific advancements made by life science and drug discovery researchers.
Discover Glo 2021 will feature industry experts and Promega scientists who will share updates on important research topics and recent technology advancements that can be applied to Kinases, GPCRs, Targeted Protein Degradation and other drug targets and research areas. In honor of the 30th anniversary of the first bioluminescence-based products launched by Promega, Bill Linton, President & CEO of Promega, will open the series with comments on the past, present and future of bioluminescent technologies.
Discover Glo 2021 daily topics:
Discover Glo 2021 speakers:
Discover Glo began in 2005 as an annual tour of European cities featuring presentations by Promega and local researchers. In 2020, the event was hosted virtually as a result of the COVID-19 pandemic. The seminars will be held virtually again in 2021, expanding access outside of Europe to researchers around the world. Register here>>
For more of the latest science news, straight to your inbox, become a member of SelectScience for free today>>